Valuation: Square Pharmaceuticals PLC.

Market Cap 187B 1.49B 1.36B 1.25B 1.13B 2.13B 139B 2.21B 15.09B 5.97B 75.27B 5.6B 5.48B 238B P/E 2026 *
7.11x
P/E 2027 * 6.33x
Enterprise Value 187B 1.49B 1.36B 1.25B 1.13B 2.13B 139B 2.21B 15.09B 5.97B 75.27B 5.6B 5.48B 238B EV / Sales 2026 *
2.18x
EV / Sales 2027 * 1.97x
Free-Float
55.9%
Yield 2026 *
6.65%
Yield 2027 * 8.32%
1 day-4.23%
1 week-4.06%
Current month-3.71%
1 month-4.28%
3 months-3.84%
6 months+1.11%
Current year+5.94%
1 week 209.2
Extreme 209.20000000
220.1
1 month 209.2
Extreme 209.20000000
220.4
Current year 198.1
Extreme 198.1
236
1 year 198
Extreme 198
236
3 years 197.2
Extreme 197.2
249.8
5 years 197.2
Extreme 197.2
249.8
10 years 149.05
Extreme 149.047619
278.67
Manager TitleAgeSince
Chief Executive Officer - 01/01/1995
Director of Finance/CFO - -
Compliance Officer - -
Director TitleAgeSince
Chairman - 01/01/2012
Director/Board Member - 01/01/1980
Director/Board Member - 01/01/2007
Change 5-day change 1-year change 3-year change Capi.($)
-4.23%-4.06%+3.54%-0.71% 1.56B
-1.13%-1.17%+38.55%+139.23% 1,275B
-1.36%-0.74%+39.64%+86.06% 680B
-0.59%-0.36%+25.14%+111.73% 521B
-0.76%+1.10%+41.43%+70.96% 389B
-0.75%-3.16%+54.39%+40.90% 356B
-1.83%-0.89%+26.00%+58.48% 305B
-1.65%-0.59%+1.55%+34.52% 287B
-0.95%-1.57%+34.01%+72.55% 250B
+1.60%-0.36%+37.21%+125.66% 208B
Average -1.16%-0.74%+30.15%+73.94% 427B
Weighted average by Cap. -0.98%-0.55%+34.95%+95.59%

Financials

2026 *2027 *
Net sales 85.4B 684M 621M 573M 517M 976M 63.87B 1.01B 6.91B 2.73B 34.46B 2.56B 2.51B 109B 94.79B 759M 689M 636M 574M 1.08B 70.89B 1.13B 7.67B 3.03B 38.25B 2.85B 2.79B 121B
Net income 26.34B 211M 191M 177M 160M 301M 19.7B 313M 2.13B 843M 10.63B 791M 775M 33.59B 29.57B 237M 215M 198M 179M 338M 22.12B 351M 2.39B 946M 11.93B 888M 869M 37.7B
Net Debt - -
Projected Income Statement - Annual - Square Pharmaceuticals PLC.
Logo Square Pharmaceuticals PLC.
Square Pharmaceuticals PLC is a Bangladesh-based pharmaceutical manufacturer and exporter. Its core business activities include the manufacture and distribution of generic pharmaceutical products, basic chemical products, and animal health products. The Company operates in one segment: the business of developing, manufacturing, and marketing drugs for healthcare for all living species. It is also involved in the distribution of crop care products. The Company offers its products in several categories, including products listed by trade name, by therapeutic class, and by generic name. In addition to conventional pharmaceuticals, it also offers products under the Herbal & Nutraceuticals category, as well as AgroVet & Pesticides, which cover veterinary and agricultural chemical products. The Company’s manufacturing facilities are located in Pabna and Dhaka, Bangladesh. Its subsidiaries include Square Lifesciences Ltd., Square Pharmaceuticals Kenya EPZ Ltd., and Samson Pharma Inc.
Employees
15,937
Date Price Change Volume
17/11/26 BDT 210.40 -4.23% 1,645,144
15/11/26 BDT 219.70 +0.41% 921,119
12/11/26 BDT 218.80 +0.09% 559,507
11/11/26 BDT 218.60 -0.32% 457,766
10/11/26 BDT 219.30 +0.09% 419,941
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
MarketScreener Ratings - Square Pharmaceuticals PLC.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
210.40BDT
Average target price
352.20BDT
Spread / Average Target
+67.40%

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Square Pharmaceuticals PLC.
  1. Stock Market
  2. Stocks
  3. SQURPHARMA Stock